World's Best Scientists 2026 revealed!
Philippe Gevaert

Philippe Gevaert

D-Index & Metrics

Immunology

D-Index
81
Citations
34559
World Ranking
1538
National Ranking
19

Overview

Philippe Gevaert is a researcher affiliated with Ghent University in Belgium. Their work primarily focuses on the field of Medicine, with a strong emphasis on Immunology and Allergy, Otorhinolaryngology, and Physiology. The research covers clinical and physiological aspects of respiratory diseases, allergic conditions, and nasal disorders.

The main topics explored in their publications include:

  • Allergic Rhinitis and Sensitization
  • Sinusitis and nasal conditions
  • Asthma and respiratory diseases
  • Nasal Surgery and Airway Studies
  • Olfactory and Sensory Function Studies
  • Respiratory and Cough-Related Research
  • Infectious Diseases and Mycology

Gevaert has contributed to a number of peer-reviewed papers, including the following recent works:

  • "European Position Paper on Rhinosinusitis and Nasal Polyps 2020" (2020), published in Rhinology Journal
  • "Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials" (2020), published in Journal of Allergy and Clinical Immunology
  • "EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management" (2020), published in Journal of Allergy and Clinical Immunology
  • "Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial" (2021), published in Journal of Allergy and Clinical Immunology
  • "EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023" (2023), published in Rhinology Journal

Frequently collaborating co-authors include:

  • Peter W. Hellings
  • Claus Bachert
  • Joaquim Mullol
  • Wytske J. Fokkens
  • Sanna Toppila-Salmi

The most frequent venues for their work include:

  • Journal of Allergy and Clinical Immunology
  • Allergy
  • The Journal of Allergy and Clinical Immunology In Practice
  • Rhinology Journal
  • Frontiers in Allergy

Philippe Gevaert's research contributions span clinical trials, expert consensus papers, and updates on therapeutic strategies, especially in relation to chronic rhinosinusitis, nasal polyps, and biologic treatments. Their work supports advancing understanding and management of respiratory and allergic diseases within otorhinolaryngology and immunology.

Best Publications

  • EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • European Position Paper on Rhinosinusitis and Nasal Polyps 2020

    Wytske J. Fokkens;Valerie J. Lund;Joachim Mullol;Claus Bachert

  • Differentiation of chronic sinus diseases by measurement of inflammatory mediators.

    T. Van Zele;S. Claeys;P. Gevaert;G. Van Maele

  • Total and specific IgE in nasal polyps is related to local eosinophilic inflammation.

    Claus Bachert;Philippe Gevaert;Gabriele Holtappels;S.G.O. Johansson

  • Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial

    Claus Bachert;Claus Bachert;Leda Mannent;Robert M Naclerio;Joaquim Mullol

  • Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

  • Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis.

    Philippe Gevaert;Nicholas Van Bruaene;Tom Cattaert;Kristel Van Steen

  • Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.

    Philippe Gevaert;Theodore A. Omachi;Jonathan Corren;Joaquim Mullol

  • Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis.

    Thibaut Van Zele;Philippe Gevaert;Jean-Baptiste Watelet;Geert Claeys

  • Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps.

    Philippe Gevaert;Doris Lang-Loidolt;Andreas Lackner;Heinz Stammberger

  • Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial.

    Claus Bachert;Claus Bachert;Ana R. Sousa;Valerie J. Lund;Glenis K. Scadding

  • Oral steroids and doxycycline: two different approaches to treat nasal polyps.

    Thibaut Van Zele;Philippe Gevaert;Gabriele Holtappels;Achim Beule

  • Pathogenesis of chronic rhinosinusitis: Inflammation

    Koen Van Crombruggen;Nan Zhang;Philippe Gevaert;Peter Tomassen

  • T-cell regulation in chronic paranasal sinus disease

    Nicholas Van Bruaene;Claudina Angela Pérez-Novo;Tomasz M. Basinski;Thibaut Van Zele

  • Nasal Polyposis: From Cytokines to Growth:

    Claus Bachert;Philippe Gevaert;Gabriele Holtappels;Claude Cuvelier

  • Non‐allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

    Unknown

  • EUFOREA Expert Board Meeting on Uncontrolled Severe Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Biologics: Definitions and Management.

    Claus Bachert;Claus Bachert;Claus Bachert;Joe K. Han;Martin Wagenmann;Werner Hosemann

  • Role of staphylococcal superantigens in upper airway disease.

    Claus Bachert;Nan Zhang;Joke Patou;Thibaut van Zele

  • Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue.

    Philippe Gevaert;Gabriële Holtappels;Sgo Johansson;Claude Cuvelier

  • Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?

    Peter W Hellings;Wytske Johanna Fokkens;Cezmi Akdis;Claus Bachert

  • Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps

    Joke Patou;Philippe Gevaert;Thibaut Van Zele;Gabriele Holtappels

  • Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

Frequent Co-Authors

Claus Bachert
Claus Bachert Karolinska Institute
Gabriele Holtappels
Gabriele Holtappels Ghent University
Joaquim Mullol
Joaquim Mullol University of Barcelona
P. Van Cauwenberge
P. Van Cauwenberge Ghent University
Ioana Agache
Ioana Agache Transylvania University of Brașov
Ludger Klimek
Ludger Klimek Ghent University
Bart N. Lambrecht
Bart N. Lambrecht Ghent University
Sven Seys
Sven Seys KU Leuven
Elina Toskala
Elina Toskala Thomas Jefferson University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare careers, particularly in nursing and specialized medical fields. For students seeking a fast track into nursing, accelerated NP programs online offer an efficient pathway to becoming a Nurse Practitioner with advanced immunological knowledge and clinical skills.

For those without a nursing background, online ABSN programs for non nurses are designed to help students quickly transition into the nursing profession. These programs emphasize foundational medical and immunological sciences, preparing graduates for diverse healthcare roles.

Selecting the right program can be challenging. Many students prioritize accessibility, making the easiest accelerated nursing programs appealing options to gain credentials swiftly while still building critical expertise in immunology-related topics.

Additionally, pursuing practical nursing through easy LPN programs to get into offers a solid health care foundation. This pathway is often accessible and provides hands-on experience that complements immunology knowledge, positioning graduates for further advancement in the medical field.

Best Scientists Citing Philippe Gevaert

Trending Scientists

Recently Published Articles